Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis

Vugar Yagublu1, Bayram Bayramov2,3, Christoph Reissfelder4,5

  • 1Department of Surgery, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. vugar.yagublu@umm.de.

Insights

Chemotherapy fails to eliminate dormant cancer cells, leading to decreased apoptosis. This study reveals chemotherapy alters gene expression, promoting cell survival and dormancy, suggesting new targets for overcoming drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Chemotherapy effectively targets rapidly dividing cells but struggles with slow-dividing cancer stem cells and dormant cells.
  • Prolonged chemotherapy exposure paradoxically reduces the proportion of apoptotic cells within tumors.

Purpose of the Study:

  • To investigate the molecular mechanisms behind chemotherapy-induced decrease in apoptosis in tumors.
  • To identify genes and pathways involved in cancer cell dormancy and survival during chemotherapy.

Main Methods:

  • Microarray-based gene expression analysis of 5-fluorouracil (5-FU) treated and untreated C-26 tumor cells.
  • Utilized a caspase-3 sensor (tHcred2-DEVD-EGFP) for monitoring apoptosis.
  • Confirmed cell purity with Fluorescence Lifetime Imaging (FLIM) and validated gene expression via RT-qPCR.

Main Results:

  • Chemotherapy induced differential expression of genes related to cancer cell dormancy and survival.
  • Observed downregulation of both intrinsic and extrinsic apoptotic signaling pathways.
  • Identified BMP7 and Prss11 as potentially significant differentially expressed genes.

Conclusions:

  • Chemotherapy promotes cancer cell dormancy and survival by altering gene expression and suppressing apoptosis.
  • BMP7 and Prss11 represent potential therapeutic targets for overcoming chemoresistance.

Related Concept Videos